Agilent Technologies (Santa Clara, California, USA) and Plasmion (Augsburg, Germany) have established a marketing collaboration for the joint marketing of the Agilent Ultivo triple‑quadrupole liquid chromatography–mass spectrometry (LC–MS) and LC/MSD iQ single‑quadrupole LC–MS instruments and the Sicrit ion source made by Plasmion.
Plasmion has developed an ionization technology, called Sicrit, which can interface with these Agilent instruments using a standard mounting bracket.
“I am glad to see that our technology and products are recognized by such a strong partner like Agilent. The combination of the Sicrit ionization technology with Agilent mass spectrometers enables customers from lab and research to boost their efficiency, flexibility, and overall performance,” said Dr. Thomas Wolf, CEO of Plasmion.
Through the agreement, the companies will market the combination of the instruments and ion source for nontraditional applications, such as the detection of volatile analytes without chromatography, in a direct mass spectrometry (MS) approach.
For more information, please visit: www.plasmion.de
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.